BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19376844)

  • 21. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
    Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY
    Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
    Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
    Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study.
    Lahousse L; Loth DW; Joos GF; Hofman A; Leufkens HG; Brusselle GG; Stricker BH
    Pulm Pharmacol Ther; 2013 Apr; 26(2):212-7. PubMed ID: 23142156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
    van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
    Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of statins in chronic obstructive pulmonary disease: is cardiovascular disease the common denominator?
    Amariei DE; Reed RM
    Curr Opin Pulm Med; 2019 Mar; 25(2):173-178. PubMed ID: 30418244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Statins in COPD--theoretical reflections].
    Hannink JD; Heijdra YF
    Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Statins out in the COLD? The STATCOPE Trial.
    Mancini GB; Road J
    Can J Cardiol; 2015 Aug; 31(8):970-3. PubMed ID: 26117620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis.
    Wang G; Shang W; Ren Y; Liu S; Ren X; Wei S; Han D
    Eur J Intern Med; 2019 Dec; 70():39-42. PubMed ID: 31679886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
    Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY
    Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.
    Holzhauser L; Hovnanians N; Eshtehardi P; Mojadidi MK; Deng Y; Goodman-Meza D; Msaouel P; Ko YA; Zolty R
    Heart Vessels; 2017 Aug; 32(8):969-976. PubMed ID: 28303379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Statins on Blood Gene Expression in COPD.
    Obeidat M; Fishbane N; Nie Y; Chen V; Hollander Z; Tebbutt SJ; Bossé Y; Ng RT; Miller BE; McManus B; Rennard S; Paré PD; Sin DD
    PLoS One; 2015; 10(10):e0140022. PubMed ID: 26462087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins as adjunct therapy in COPD: how do we cope after STATCOPE?
    Young RP; Hopkins RJ; Agusti A
    Thorax; 2014 Oct; 69(10):891-4. PubMed ID: 25015240
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies.
    Horita N; Miyazawa N; Kojima R; Inoue M; Ishigatsubo Y; Ueda A; Kaneko T
    Respir Res; 2014 Jul; 15(1):80. PubMed ID: 25029928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of perioperative statin therapy for noncardiac surgery.
    Skrlin S; Hou V
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological actions of statins: potential utility in COPD.
    Young RP; Hopkins R; Eaton TE
    Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.